NDC 68788-8560-03 - METFORMIN HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8560
- Requested NDC
- 68788-8560-03
- Package NDCs from labels
- 68788-8560-3, 68788-8560-6, 68788-8560-9, 68788-8560-1, 68788-8560-8, 68788-8560-03
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-06-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| METFORMIN HYDROCHLORIDE - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-06-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8560-1 | METFORMIN HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 68788-8560-3 | METFORMIN HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 68788-8560-6 | METFORMIN HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 68788-8560-8 | METFORMIN HYDROCHLORIDE | 120 in 1 BOTTLE | TABLET | 120 | 2 | |
| 68788-8560-9 | METFORMIN HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8560 | METFORMIN HYDROCHLORIDE TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 5 package rows | 20240203_4182bcf0-1f9a-4f3a-9428-86b5d757954f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8560-1 | EA - Each | 68788-8560 | a6280390-6bda-4680-bac5-46d67bc44fe3 | 1 | 2024-05-16 |
| 68788-8560-3 | EA - Each | 68788-8560 | 2f8184f9-e98d-4b5d-a192-2ef22b89076a | 1 | 2024-05-16 |
| 68788-8560-6 | EA - Each | 68788-8560 | 4bb23106-357e-41d5-bcca-a52a15a498aa | 1 | 2024-05-16 |
| 68788-8560-8 | EA - Each | 68788-8560 | 2a50cee6-d71f-4579-b736-3a25c6ac8a85 | 1 | 2024-05-16 |
| 68788-8560-9 | EA - Each | 68788-8560 | bab66442-b297-4b29-a899-7eb59d83d8a6 | 1 | 2024-05-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | d5228e81-9c86-4781-b984-20feaa2ae779 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | REMEDYREPACK INC. | 05999192-ebc6-4198-bd1e-f46abbfb4f8a | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Stay Ageless Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | W Aesthetics | 5b0f2c8f-d6fa-5e25-e063-6394a90a084d | 2026-09-09 | Warnings | 15FIX9V2JP |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 7cc02a26-5c22-445b-ad8f-3e7570c143d3 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Granules India Ltd | 73197cb5-3e23-4ac0-b189-f9bc848bce66 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | b6d7edc9-93d6-4480-906d-55c18d053600 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | ANDA213320 861007 786Z46389E |
| Pioglitazone Hydrochloride and Metformin Hydrochloride | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 1fa2703e-fb73-44d5-aaa2-b12b1090d42c | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone HCL and Metformin HCL | PIOGLITAZONE HCL AND METFORMIN HCL | Torrent Pharmaceuticals Limited | 237d8fa2-633c-4c29-84d3-f1b413610dc3 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 64f5b140-7ad8-4c07-bbfc-ae4618afa850 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | ANDA213320 861007 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | bfd6ec0f-8264-4877-aa6d-f347f53bc426 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | c568d49f-c040-4f1e-ad36-77b05ab659c3 | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| MZANK SUNSCREEN DAILY ULTIMATE PROTECTION SPF50 | SUNSCREEN SPF50 | Guangzhou Meixi Biotechnology Co., Ltd. | 5a0b4bd2-f6ad-35dc-e063-6294a90a8a66 | 2026-08-27 | Warnings | 15FIX9V2JP |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ba0379cb-824e-4798-9ff9-99bcd1bea5cb | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| MELAO Hydrating Lightweight Sunscreen | AVOBENZONE,ENSULIZOLE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,TITANIUM DIOXIDE | Guangdong Aimu Biological Technology Co., Ltd | 59eeaea1-d726-99f3-e063-6394a90aeea3 | 2026-08-26 | Warnings | 15FIX9V2JP |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | fb296500-55cb-45ce-be0c-59aa2e3d4624 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Q Skin Science | SUNSCREEN | International Cosmeceuticals, Inc | 59e4c3d0-ee4c-2350-e063-6394a90ac9d2 | 2026-08-25 | Warnings | 15FIX9V2JP |
| Synjardy | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| alogliptin and metformin hydrochloride | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.